D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Tomaszewski JE, Wein A. Prostate specific antigen outcome based on the extent of extracapsular extension and margin status in patients with seminal vesicle negative prostate carcinoma of Gleason Score < 7. Cancer 2000; 88:2110-2115.
D'Amico AV, Whittington R, Malkowicz SB, Wu YH, Chen MH, Art M, Tomaszewski JE, Wein A. The combination of the preoperative PSA level, biopsy Gleason score, percent positive biopsies and MRI T-stage to predicte early PSA failure in men with clinically localized prostate cancer. Urology 2000; 55:752-576.
D'Amico AV, Weinstein M, Li X, Richie JP, Fujimoto J. Optical coherence tomography as a method for identifying benign and malignant microscopic structures in the prostate gland. Urology 2000; 55:783-787.
D'Amico AV, Whittington R, Malkowicz SB, Wu YH, Chen MH, Hurwitz M, Kantoff P, Tomaszewski JE, Renshaw AA, Wein A, Richie JP. Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant therapy trials. J Clin Oncol 2000; 18:3240-3246.
D'Amico AV, Whittington R, Malkowicz SB, Schnall M, Schultz D, Cote K. Tomaszewski JE, Wein A. Endorectal magnetic resonance imaging as a predictor of biochemical outcome following radical prostatectomy for men with clinically localized prostate cancer. J Urol 2000; 164:759-763.
D'Amico AV, Schultz D, Schneider L, Hurwitz M, Kantoff PW, Richie JP. Comparing prostate specific antigen outcomes after different types of radiotherapy management of clinically localized prostate cancer highlights the importance of controlling for established prognostic factors. J Urol 2000; 163:1797-1801.
D'Amico AV, Cormack R, Kumar S, Tempany CM. Real-time magnetic resonance imaging-guided brachytherapy in the treatment of selected patients with clincially localized prostate cancer. J Endourology 2000; 14:367-370.
D'Amico AV, Tempany CM, Cormack R, Hata N, Jinzaki M, Tuncali K, Weinstein M, Richie JP. Transperineal magnetic resonance image guided prostate biopsy. J Urol 2000; 164:385-387.